ABLE’s BioEconomy Conclave to be held in Bengaluru
The two-day conclave from January 31 to Febrauary 1, will have nine sessions dedicated to different segments of bioeconomy
Author
Strides board approves $15 m investment in Stelis Biopharma
The first close of the current fund raise is $35 million, of which Strides will commit $15 million and $20 million is from other…
Roche-AbbVie cancer drug gets accelerated FDA approval
The drug, developed in partnership with AbbVie, was approved for patients with acute myeloid leukemia
US FDA approves new blood cancer treatment from Pfizer
The company plans to launch the drug, Daurismo, in the US by early December with a monthly list price of $16,925
Glenmark receives ANDA approval for Atovaquone Oral Suspension USP, 750 mg/5 mL
The drug is the generic version of Mepron 1 Oral Suspension, 750 mg/5 mL, of GlaxoSmithKline
Piramal Pharma Solutions unveils cGMP kilo lab suite for API
The suite in Chennai will formally open on December 1, 2018
US court rules in favour of DRL on generic Suboxone
A patent infringement case was filed by pharma giant Indivior on selling generic version of Suboxone
Dr Reddy's Laboratories…
Lupin launches generic of Xenazine in US
The company has received approval from US FDA earlier this year
Handful of pharma companies developing urgently needed new medicines for poor: The Access to…
The analysis indicates that the majority of the priority R&D projects are being carried out with public sector research…
ICT to organise 2nd Biosimilar Workshop 2018 in Mumbai
The event will be conducted in collaboration with US Pharmacopeia, BIRAC, C-CAMP and ABLE
Institute of Chemical Technology (ICT)…